Differences in Platelet Enzyme Activity between Alcoholics and Nonalcoholics

New England Journal of Medicine

Volumn 318, Issue 3, 1988, Pages 134-139

  Tabakoff, Boris ^a   Hoffman, Paula L ^a   Lee, John M ^a   Saito, Toshikazu ^a   Willard, Barbara ^a   de Leon Jones, Frank ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING); CESIUM FLUORIDE; GUANINE NUCLEOTIDE; PROSTAGLANDIN E1; UNCLASSIFIED DRUG;

ALCOHOLISM; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0023850295     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198801213180302     Document Type: Article

References (31)

1. Watson RR, Mohs ME, Eskelson C, Sampliner RE, Hartmann B. Identification of alcohol abuse and alcoholism with biological parameters. Alcoholism (NY) 1986; 10: 364–85.
2. Saito T, Lee JM, Hoffman PL, Tabakoff B. Effects of chronic ethanol treatment on the β-adrenergic receptor-coupled adenylate cyclase system of mouse cerebral cortex. J Neurochem 1987; 48: 1817–22.
3. French SW, Palmer DS, Narod ME, Reid PE, Ramey CW. Noradrenergic sensitivity of the cerebral cortex after chronic ethanol ingestion and withdrawal. J Pharmacol Exp Ther 1975; 194: 319–26.
4. Collins GGS, Sandler M. Human blood platelet monoamine oxidase. Biochem Pharmacol 1971; 20: 289–96.
5. Bohman M. Some genetic aspects of alcoholism and criminality: a population of adoptees. Arch Gen Psychiatry 1978; 35: 269–76.
6. Schuckit MA. Alcoholism and genetics: possible biological mediators. Biol Psychiatry 1980; 15: 437–47.
7. Gottfries CG, Oreland L, Wiberg Å, Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J Neurochem 1975; 25: 667–73.
8. Wiberg Å, Gottfries C-G, Oreland L. Low platelet monoamine oxidase activity in human alcoholics. Med Biol 1977; 55: 181–6.
9. Major LF, Murphy DL. Platelet and plasma amine oxidase activity in alcoholic individuals. Br J Psychiatry 1978; 132: 548–54.
10. Alexopoulos GS, Lieberman KW, Frances R, Stokes PE. Platelet MAO during the alcohol withdrawal syndrome. Am J Psychiatry 1981; 138: 1254–5.
11. Sullivan JL, Stanfield CN, Maltbie AA, Hammett E, Cavenar JO Jr. Stability of low blood platelet monoamine oxidase activity in human alcoholics. Biol Psychiatry 1978; 13: 391–7.
12. American Psychiatric Association Task Force on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, D.C.: American Psychiatric Association, 1980.
13. Cahalan D. Problem drinkers. San Francisco: Jossey-Bass, 1970.
14. Spitzer RL, Endicott J, Robins E, Kuriansky J, Gurland B. Preliminary report of the reliability of Research Diagnostic Criteria applied to psychiatric case records. In: Sudilovsky A, Gershon S, Beer B, eds. Predictability in psychopharmacology: preclinical and clinical correlations. New York: Raven Press, 1975:1–47.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.
16. Tabakoff B, Alivisatos SGA. Modified method for spectrophotometric determination of monoamine oxidase activity. Anal Chem 1972; 4: 427–8.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.
18. Wurtman RJ, Axelrod J. A sensitive and specific assay for the estimation of monoamine oxidase. Biochem Pharmacol 1963; 12: 1439–41.
19. Tabakoff B, Hoffman P, Moses F. Neurochemical correlates of ethanol withdrawal: alterations in serotonergic function. J Pharm Pharmacol 1977; 29: 471–6.
20. Joyner SP, ed. SAS Institute. SAS/STAT guide for personal computers, version 6 edition. Cary, N.C.: SAS Institute, 1985.
21. Dixon WJ, ed. BMDP statistical software manual: 1985 reprinting. Berkeley, Calif.: University of California Press, 1985:519–37.
22. Morton NE, Rao DC, Lalouel J-M. Methods in genetic epidemiology. Basel: S. Karger, 1983.
23. Gross MM, Lewis E, Nagarajan M. An improved quantitative system for assessing the acute alcoholic psychoses and related states (TSA and SSA). In: Gross MM, ed. Advances in experimental medicine and biology. Vol. 35. Alcoholic intoxication and withdrawal: experimental studies. New York: Plenum Press, 1973:365–76.
24. Mann JJ, Kaplan RD, Georgotas A, Friedman E, Branchey M, Gershon S. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics. Psychopharmacology (Berlin) 1981; 74: 344–8.
25. Oreland L, Wiberg Å, Winblad B, Fowler CJ, Gottfries C-G, Kiianmaa K. The activity of monoamine oxidase -A and -B in brains from chronic alcoholics. J Neural Transm 1983; 56: 73–83.
26. Tabakoff B, Lee JM, De Leone-Jones F, Hoffman PL. Ethanol inhibits the activity of the B form of monoamine oxidase in human platelet and brain tissue. Psychopharmacology (Berlin) 1985; 87: 152–6.
27. Major LF, Goyer PF, Murphy DL. Changes in platelet monoamine oxidase activity during abstinence. J Stud Alcohol 1981; 42: 1052–7.
28. Cloninger CR, Bohman M, Sigvardsson S. Inheritance of alcohol abuse: cross-fostering analysis of adopted men. Arch Gen Psychiatry 1981; 38: 861–8.
29. von Knorring A-L, Bohman M, von Knorring L, Oreland L. Platelet MAO activity as a biological marker in subgroups of alcoholism. Acta Psychiatr Scand 1985; 72: 51–8.
30. Smigel M, Katada T, Northup JK, Bokoch GM, Ui M, Gilman AG. Mechanisms of guanine nucleotide-mediated regulation of adenylate cyclase activity. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984; 17: 1–18.
31. Diamond I, Wrubel B, Estrin W, Gordon A. Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes in alcoholic patients. Proc Natl Acad Sci USA 1987; 84: 1413–6.